Drug Profile
Research programme: depression and cognitive deficit therapeutics - Chakra Biotech
Alternative Names: CB 010001; CB 010008; CB 010011Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chakra Biotech
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders; Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in Singapore
- 16 Jul 2016 No recent reports of development identified for preclinical development in Major depressive disorder in Singapore
- 11 Sep 2007 Preclinical trials in Cognition disorders in Singapore (unspecified route)